T-0156 is a potent and selective phosphodiesterase type 5 (PDE5) inhibitor; it competitively and specifically inhibits PDE5-mediated hydrolysis of cyclic guanosine monophosphate (cGMP) (IC50 = 0.23 nM); it enhances the nitric oxide (NO)/cGMP signaling pathway.